Home > Insider Trading > Filing (0001415889-22-005501)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819411	Gain Therapeutics Inc.	GANX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313876	I Eric Richman	C/O Gain Therapeutics, Inc. 4800 Montgomery Lane, Suite 220 Bethesda MD 20814	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-19	4,000	$2.71	205,991	No	4	P	Direct
Common Stock	Acquisiton	2022-05-20	9,256	$2.83	215,247	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,829	Indirect	By Trust

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownershipof the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.